What is human menopausal gonadotropin?

Human menopausal gonadotropin (HMG) is a type of fertility drug that the doctor will be injected. It is often used to increase pregnancy chances for those who have fertility problems. These shots are stimulated by female ovaries to produce several eggs, unlike one. Sometimes it can also be given to a male patient who has a low number of sperm, which is the result of low levels of gonadotropins produced in the body. Injections of human menopausal gonadotropin contain two hormones that are naturally produced by pituitary gland: luteinizing hormone (LH) and hormone stimulating follicles (FSH). Before further treatment of fertility, such as in vitro fertilization, the patient often undergoes injection of human menopausal gonadotropin. Since hormonal shots stimulate more eggs to develop, the doctor may harvest other eggs, which can then be fertilized outside the uterus. Anopostup that is often used in this treatment is intrauterine insemination in which sperm injoits intouterus. Having multiple eggs for fertilization increases the chances of conception.

Human menopausal injection of gonadotropin will soon begin in the menstrual cycle of a woman. The doctor gives an injection every day for seven to 12 days. After the treatment of HMG shots, the patient will undergo one injection of human chorionic gonadotropin (HCG). After HMG stimulates the production of other eggs, HCG injections cause ovulation. This means that these ripe eggs will then be released into the fallopian tubes.

While this treatment of fertility can help more than half of women to become pregnant, approximately one third of these women suffer from abortion. Patients of Aware should be potential risks before injection of human menopausal gonadotropin. In addition to risking possible abortion, the patient may sometimes be susceptible to ovarian hyperstimulation syndrome. This may require treatment in bed, intravenous fluids and possible hospitalization together witha medical procedure for repairing excess fluid in the abdomen. Doctors will monitor patients often during blood test injections and ultrasound to help prevent this complication.

Other complications and side effects are also possible in human menopausal gonadotropin. Men who receive it may notice breast enlargement, which is temporary. Also, abdominal pain and headaches are possible. Women may be more susceptible to enlargement of the ovaries. More pregnancies are also more likely, which may be more risk than individual pregnancies.